Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-01-11 4:40:43 am | Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday | InvestorPlace |
| 2023-11-27 3:14:0 am | QLGN: Dosing Begins in Phase 1 Trial of QN-302… | Zacks Small Cap Research |
| 2023-11-14 1:30:0 pm | Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023 | GlobeNewswire |
| 2023-11-07 5:30:0 am | Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors | GlobeNewswire |
| 2023-10-23 5:30:0 am | Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor Platform Presented at AACR Special Conference: Advances in Breast Cancer | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information